Shri Ahimsa Naturals Limited — Important, 28-05-2026: Disclosure of material issue

**SHRIAHIMSA Update:** The Board approved significant enhancements for its Sawarda, Jaipur manufacturing plant (via WOS Shri Ahimsa Healthcare). This includes adding decaffeination, Green Coffee Bean Extract (GCE) enrichment, fungible botanical extraction processes, and plant automation systems.

**Impact:** These upgrades aim to substantially boost operational capabilities, efficiency, and scalability. Expected benefits include significant cost optimization, improved raw material security, higher production, product portfolio expansion, and overall operational efficiency.

**Funding & Timeline:** The enhancements entail an additional ₹70 Cr capital expenditure, funded by ₹32.57 Cr from preferential allotment (of Equity Shares/Warrants), ₹25 Cr from a bank term loan, and ₹12.43 Cr from internal accruals. Plant commissioning is now targeted for March 2027 (revised schedule).